Peel Hunt restated their buy rating on shares of ConvaTec Group PLC (LON:CTEC) in a research report report published on Thursday. Peel Hunt currently has a GBX 380 ($4.96) price target on the stock.
CTEC has been the subject of several other reports. HSBC Holdings plc reissued a buy rating and issued a GBX 330 ($4.31) price objective on shares of ConvaTec Group PLC in a research report on Wednesday, April 26th. Deutsche Bank AG reissued a buy rating and issued a GBX 330 ($4.31) price objective on shares of ConvaTec Group PLC in a research report on Monday, May 8th. J P Morgan Chase & Co reissued an overweight rating and issued a GBX 305 ($3.98) price objective on shares of ConvaTec Group PLC in a research report on Thursday, March 30th. Goldman Sachs Group, Inc. (The) reissued a buy rating and issued a GBX 340 ($4.44) price objective on shares of ConvaTec Group PLC in a research report on Friday, June 30th. Finally, Royal Bank Of Canada boosted their price objective on shares of ConvaTec Group PLC from GBX 242 ($3.16) to GBX 278 ($3.63) and gave the company a sector perform rating in a research report on Thursday, March 23rd. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have assigned a buy rating to the company. The company currently has an average rating of Buy and an average price target of GBX 314 ($4.10).
Shares of ConvaTec Group PLC (LON:CTEC) traded up 1.66% during trading on Thursday, hitting GBX 313.20. The stock had a trading volume of 6,152,567 shares. The company’s market capitalization is GBX 6.03 billion. ConvaTec Group PLC has a 52 week low of GBX 213.00 and a 52 week high of GBX 349.10. The company’s 50 day moving average price is GBX 318.88 and its 200 day moving average price is GBX 280.39.
ConvaTec Group PLC Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.
